OGDEN, Utah, June 2, 1999 (PRIMEZONE) -- Computerized Thermal Imaging, Inc. (OTC BB: COII) (CTI), announced today the appointment of Lynn H. Satterthwaite as Vice President of Engineering. Mr. Satterthwaite's initial focus will be to complete the preparation of CTI's proprietary breast cancer system for commercial sales. In this effort, he will work closely with CTI's internal technical staff as well as The Company's technical support contractors. He will be assuming the duties of this newly created position immediately.
Mr. Satterthwaite brings over 24 years experience to CTI working with advanced technology systems in both the private and government sectors. Most recently, he served nine years as a senior manager for TRW Space and Electronics Group. Prior to that, he spent 15 years at the United States Navel Weapons Center, China Lake, CA. In both of these positions, he was involved with the development and management of numerous high-level projects focusing on critical technology systems. He is also a Lead Assessor, certified by the Software Engineering Institute. As such, he evaluates and rates both government and commercial organization software development practices.
"I am very excited to have Lynn join us," said David A. Packer, CTI's president. "It's not often that you can find an executive with such an impressive technology and management background, and we believe that his software assessment experience will prove to be invaluable. His appointment comes at a crucial time in the Company's transition from research and development to commercial deployments of our software intensive, algorithm based breast cancer detection system."
Lynn holds a B. S. Degree in Mechanical Engineering from Utah State University, with an emphasis in thermodynamics, heat transfer and fluid mechanics.
CTI is seeking approval for the Thermal Breast Imaging System as an adjunctive diagnostic test to mammogram and clinical examination for the detection of breast cancer. The system is currently undergoing multi-center clinical trials to test its efficacy in differentiating benign from malignant breast abnormalities. The test is simple, painless and requires no exposure to radiation, no electrodes or breast compression. Computerized Thermal Imaging, Inc. develops and deploys thermal imaging and associated technologies for use in the enhancement of medical screening, diagnosis and patient management. More information about CTI can be found on the Internet at www.cti-net.com or by calling CTI Public Affairs at (801) 776-4700.
Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition to the factors set forth above, other important factors that could cause actual results to differ materially include, but are not limited to technical risks associated with new technology development, government regulatory approvals or continued working capital. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained from time to time in the Company's SEC filings. Copies of these filings may be obtained by contacting the Company or the SEC.
-0-